Internal Medicine · Norcross, GA
NPI
1891786497
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6330 Primrose Hill Ct
Norcross, GA, 30092
Phone (404) 385-0160
Groups this clinician bills Medicare through
Medicare paid, 2024
$500K
13,776 services
Medicare patients, 2024
667
Average age 79
Drug cost, 2024
$5.0M
37,791 prescriptions
Company payments, 2025
$272
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Galina Vayner was code 99490 (chronic, principal, and transitional care management), 2,273 times for 267 patients. In total Galina Vayner billed 13,776 services in 139 codes, and Medicare paid $500K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,273 | 267 | $43.62 | $99K |
| 99213 Office E&M - Established | Office | 1,334 | 525 | $55.52 | $74K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,084 | 132 | $0.65 | $700 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 1,024 | 147 | $0.49 | $505 |
| 97140 PT Treatment | Office | 849 | 83 | $18.08 | $15K |
| 81002 Clinical Chemistry | Office | 735 | 481 | $3.41 | $2,506 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 613 | 23 | $0.24 | $145 |
| 96372 Injection Administration | Office | 570 | 269 | $9.05 | $5,159 |
| J7323 Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 546 | 47 | $94.38 | $52K |
| 20610 Joint Injection | Office | 420 | 74 | $47.66 | $20K |
| 77002 Imaging - Miscellaneous | Office | 415 | 72 | $80.69 | $33K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 378 | 378 | $127.53 | $48K |
| 97035 PT Treatment | Office | 323 | 56 | $8.09 | $2,613 |
| 93000 Electrocardiogram | Office | 314 | 280 | $8.33 | $2,616 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 280 | 165 | $0.73 | $204 |
By year: 2022 $663K for 19,399 services; 2023 $494K for 14,222 services; 2024 $500K for 13,776 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 735 | 481 | $3.41 | $2,506 |
| 82274 Immunoassay | 162 | 146 | $15.60 | $2,527 |
| 82044 Clinical Chemistry | 141 | 127 | $6.11 | $862 |
| 82962 Clinical Chemistry | 82 | 70 | $3.21 | $263 |
| 83036 Blood Count | 50 | 49 | $9.52 | $476 |
| 87804 Immunoassay | 22 | 11 | $16.22 | $357 |
Medicare prescription drug claims, 2024
In 2024, the drug Galina Vayner prescribed most often to Medicare patients was Amlodipine Besylate, with 1,646 prescriptions and refills. In total Galina Vayner wrote 37,791 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,646 | 4,028 | 436 | $4,721 |
| Metformin Hcl Generic | 1,479 | 3,742 | 371 | $5,915 |
| Omeprazole Generic | 1,469 | 3,245 | 356 | $12K |
| Atorvastatin Calcium Generic | 1,415 | 3,746 | 409 | $7,360 |
| Alendronate Sodium Generic | 981 | 2,373 | 282 | $5,757 |
| Gabapentin Generic | 852 | 1,753 | 211 | $9,320 |
| Levothyroxine Sodium Generic | 805 | 2,098 | 195 | $5,987 |
| Lisinopril Generic | 749 | 1,890 | 207 | $2,674 |
| Tamsulosin Hcl Generic | 684 | 1,701 | 179 | $5,174 |
| Losartan Potassium Generic | 653 | 1,596 | 173 | $4,260 |
| Diclofenac Sodium Generic | 635 | 693 | 189 | $20K |
| Rosuvastatin Calcium Generic | 597 | 1,659 | 185 | $7,620 |
| Pravastatin Sodium Generic | 589 | 1,547 | 156 | $5,415 |
| Metoprolol Succinate Generic | 566 | 1,357 | 145 | $5,655 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 557 | 1,465 | 167 | $4,996 |
Brand drugs: 5,583 claims; generic drugs: 31,711 claims; opioid claims: 348.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Galina Vayner $272 ($272 in general payments such as food, travel and fees) from 9 companies. The largest payer was GlaxoSmithKline, LLC. with $54.9.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 3 | $54.9 |
| Novo Nordisk Inc NVO | 2 | $49.3 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $44.16 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $36.27 |
| Corcept Therapeutics CORT | 1 | $21.52 |
| Xeris Pharmaceuticals, Inc. | 1 | $21.4 |
| Aimmune Therapeutics, Inc. | 1 | $16.33 |
| Exact Sciences Corporation EXAS | 1 | $14.14 |
| Amgen Inc. AMGN | 1 | $13.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.